Comparación de la eficacia del factor de necrosis tumoral agentes bloqueadores adalimumab, etanercept e infliximab cuando se añade a metotrexato en pacientes con artritis reumatoide activa

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2005
Cargando información sobre las referencias

CRD SUMMARY:

This review compared adalimumab, etanercept and infliximab when added to methotrexate in patients with active rheumatoid arthritis. The authors concluded that the three agents have similar efficacy when combined with methotrexate. Overall, the methods of analysis may mean that the trials were not powered to detect any true treatment effect differences. Head-to-head comparisons between the three drugs are therefore warranted.
Epistemonikos ID: c65d54f1e40f551ec7427cbbc3e3a864aa567980
First added on: Jun 06, 2012